Trial intelligence / Profile preview

Duloxetine long-term safety in SUI

NCT00190632Phase 3Completed

Sponsor
Eli Lilly and Company
Start
Mar 2001
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of duloxetine in stress urinary incontinence (SUI), sponsored by Eli Lilly and Company. Started Mar 2001; status: completed.

02

Drugs

duloxetine
03

Conditions

stress urinary incontinence (SUI)

Beyond the preview

Go deeper on NCT00190632.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00190632.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call